Overall Status

Completed (18)

Not yet recruiting (3)

Recruiting (3)

Active, not recruiting (2)

Unknown status (2)

Terminated (1)

Phase

phase 2 (10)

phase 3 (7)

n/a (3)

phase 2/phase 3 (2)

phase 1 (1)

phase 1/phase 2 (1)

phase 4 (1)

Study Documents

Intervention Type

drug (20)

other (4)

biological (3)

diagnostic test (1)

dietary supplement (1)

procedure (1)

Funder Type

Other (21)

NIH (3)

U.S. Fed (3)

Industry (2)

Study Type

Interventional (25)

Observational (4)

Tuberculosis

Showing NaN - NaN of 29

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pilot Study of Surrogate Markers for Outcome of TB Treatment

Completed

Tuberculosis

Nucleic Acid Amplification Methods for diagnosis

Little Rock, Arkansas
+13 more

Aug 2, 2011

HIV, Tuberculosis Trial in Durban (rifabutin in combination with efavirenz, rifabutin in combination with nevirapine, rifabutin

Completed

HIV Infections
Tuberculosis

rifabutin in combination with efavirenz
+2 more

Durban, South Africa

Unit for Clinical and Biomedical TB Research (Medical Research C

Jun 17, 2011

HIV, Tuberculosis Trial in Durban (Early versus intermediate versus late initiation of ART)

Completed

HIV Infections
Tuberculosis

Early versus intermediate versus late initiation of ART

Durban, KwaZulu-Natal, South Africa

CAPRISA eThekwini Clinical Research Site

Mar 23, 2011

Tuberculosis Trial in Worldwide (Gatifloxacin combined regimen)

Unknown status

Tuberculosis

Gatifloxacin combined regimen

Cotonou, Benin
+4 more

Sep 20, 2005